QIAGEN enhances leading clinical genomics portfolio with acquisition of Genoox AI-powered software

About this update from Qiagen N.v.

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":242,"height":204,"url":"https://media.zenfs.com/en/business-wire.com/bb5c1294ec37bfd21480600aba508f6e"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/u2S3lDh0KzGkUTKLqw1WKA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTM1NDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/bb5c1294ec37bfd21480600aba508f6e","width":242,"height":204}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Acquisition adds Franklin solution, an AI-powered cloud platform for clinical decision support in genetic diseases","length":114,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Strengthens QIAGEN Digital Insights offering for small and mid-sized labs worldwide with easy-to-use, fast and flexible NGS data interpretation in a rapidly growing market","length":171,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Franklin complements QCI Interpret, QCI Precision Insights and QIAGEN’s leading genetic databases COSMIC and HGMD","length":113,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":398,"olType":false},{"type":"text","content":"VENLO, the Netherlands & TEL AVIV, Israel, May 12, 2025--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it has signed a definitive agreement to acquire Genoox, a provider of AI-powered software that enables clinical labs to scale and accelerate the processing of complex genetic tests.","length":326,"tagName":"p"},{"type":"text","content":"The acquisition adds Franklin, Genoox’s flagship cloud-based community platform, to the QIAGEN Digital Insights (QDI) portfolio, strengthening QIAGEN’s leadership in genetic interpretation for clinical genomics applications.","length":224,"tagName":"p"},{"type":"text","content":"Franklin empowers labs to analyze next-generation sequencing (NGS) data – from targeted gene panels to whole exome and genome sequencing (WES/WGS) - and delivers real-time, AI-driven insights to support clinical decision-making. Applications range from diagnosing genetic disorders and informing cancer treatments to supporting family planning decisions.","length":354,"tagName":"p"},{"type":"text","content":"The platform is currently used by more than 4,000 healthcare organiz...

More updates from Qiagen N.v.